Lyrfigtu (lirafugratinib), a once-daily pill, is for previously treated cholangiocarcinoma with an FGFR2 fusion or ...

BioNTech (NASDAQ:BNTX) shares declined 5% on Tuesday after the biotechnology company reported that its investigational mRNA cancer therapy, BNT113, failed to meet an initial primary endpoint in a ...

New York student Amy Xiao has used computational modelling and lab experiments to investigate whether a protein called citrin ...

For many women facing a mastectomy, surgery can mean more than removing cancer. It may also result in visible scarring and loss of breast sensation. At MedStar Georgetown University Hospital, a new ...

Scientists identified a driver of aggressive prostate cancer and a potential way to stop drug-resistant tumors forming.

ATLANTA — Go ahead. Exhale. The Ravens salvaged a primetime contest they repeatedly threatened to give away, overcoming squandered scoring chances, a costly early fumble and a defense that couldn’t ...

Treatments for the most common form of adult leukemia, chronic lymphocytic leukemia (CLL), have changed dramatically over the ...

Surgery linked to more urinary and sexual side effects, while radiation associated with other urinary complications and higher all-cause mortality ...

An analysis of nearly half a million cells from dozens of patients' tumors reveals how cancer cells continuously reshape ...

Thanks to new research, we’re learning more about a twist in the relationship between body weight and cancer survival that ...

Scientists are highlighting long non-coding RNAs (lncRNAs) as promising targets in the effort to overcome one of cancer treatment's most persistent challenges: therapeutic resistance.

A new treatment for severe and debilitating ovarian cancer has been approved for use on the NHS in Scotland for the first ...